ARTICLE | Company News
ANI Pharmaceuticals sales and marketing update
August 1, 2016 7:00 AM UTC
ANI launched a generic version of Nilandron nilutamide from Sanofi (Euronext:SAN; NYSE:SNY, Paris, France) in the U.S. The oral testosterone blocker is marketed to treat metastatic prostate cancer. ...